Trilliome

Women’s Health & Maternity · Pharmacies

Overview

Your gut is the body's pharmacy, and with age it runs low. Trilliome makes plant-derived actives that switch the gut's protective bacteria back on, for brain, metabolic and women's health.

Funding and backers

Backers
1
Blue Lion
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 14 Recognition Trilliome is a MassChallenge 2026 Winner · trilliome.com Oct 1, 2025 Recognition Trilliome Wins 1st Prize in EIT Food's "Food as Medicine" Accelerator and Expands Global Recognition · trilliome.com
Registers and programsofficial lists and records that name the company
Legal entity Trilliome GmbH its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
WellVenture round · 4 mo ago · Founded 2020
Well Pharmacy are a top UK pharmacy providing free prescription deliveries, consultations and health services from 780 local branches. Get…
FemovateFounded 2022
Femovate fuels women’s health innovation with design capital and product research & design. With 70+ portfolio companies, we advance…
Ema EQFounded 2019
Ema is the leading AI for women's health. An emotionally intelligent care platform trained on 10M+ real health conversations, built for…
A new kind of pharmacy pos. Emporos' modern software integrates across a variety of segments with the same results: making pharmacy…
AfyniaSeed $5M · 20 mo ago · 51-200 employees
Your trusted source for information and fast, easy-to-use products for women's health conditions.
TUUNEVenture round · 6 mo ago · 11-50 employees
Tuune is a personalized women's healthcare company that is dedicated to improving the management of hormonal conditions for women.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Blue LionVia a fund
208 portfolio companies: Ernst Göhner Stiftung, Wenger Vieli Ltd., Baugarten Zuerich and 205 more

News

Award 24 days ago
Trilliome is a MassChallenge 2026 Winner
We are a MassChallenge 2026 Winner. On 29 October, we pitch live at the Awards in Lausanne.
Read more
Report
Blog 1 month ago
Tim Mak lectures at the Geneva College of Longevity Science
On October 12, our co-founder Tim Mak gives an online GCLS guest lecture on how the gut microbiome shapes aging, and how precision bioactives can steer it.
Read more
Report
Blog 1 month ago
Mopping off the floor without turning off the faucet
That is how Alice Park of TIME framed the pharma chief executive panel she moderated at ARDD 2026 at Harvard on Friday morning: mopping off the floor without turning off the faucet. On stage were Christophe Weber, ex-CEO of Takeda; Elcin Barker Ergun, CEO
Read more
Report
Blog 1 month ago
Trilliome at ARDD 2026, Harvard
Patrick Guye is at the 13th Aging Research & Drug Discovery Meeting in Boston, 1-3 October. Day one: XPRIZE Healthspan shows ingredients moving into aging…
Read more
Report
Blog 2 months ago
Pilot Manufacturing
In August, Bühler ran our first pilot production at its application center in Uzwil. We optimized the manufacturing process, on a line that makes hundreds…
Read more
Report
Press release 3 months ago
The brain is not sealed
The immune cells defending your brain were supposed to last a lifetime. New human data shows they start being replaced around fifty, and the replacements…
Read more
Report
Blog 4 months ago
A remote control for memory, hidden in the gut
Take a young mouse. Put it in a cage with an old one for a month. Nothing measurable changes inside its brain - no plaques, no dead neurons, no shrinkage. And yet its memory falls apart. It forgets an object it inspected minutes earlier, and it loses its
Read more
Report
Blog 5 months ago
A GLP-1 drug treated depression without touching its receptor
A GLP-1 drug relieved depression in mice. Then the researchers deleted the receptor it was supposed to act on, and it kept working. The effect wasn't coming from the brain. It was coming from the gut. This is from a study published in June 2026 in Cell Ho
Read more
Report
Blog 5 months ago
Beyond biotics: the case for precision bioactives
Thesis: Probiotics add live bacteria and fibre feeds them in bulk. A precision bioactive does something different - a small, plant-derived molecule that reprogrammes the beneficial bacteria a person already carries. Fi Global recently asked whether precis
Read more
Report
Blog 5 months ago
We're in. Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Zurich Switzerland
HQ
company site